+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Blood Transfusion Devices Market, By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others), By Blood Component (Whole Blood, Plasma, RBC, Others), By End User, By Region, Forecast & Opportunities, 2026

  • ID: 5439257
  • Report
  • December 2021
  • Region: Global
  • 116 Pages
  • TechSci Research
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

FEATURED COMPANIES

  • B Braun Melsungen AG
  • Fresenius Kabi AG
  • Grifols SA
  • Haemonetics Corporation
  • Immucor Inc
  • Kaneka Corporation
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

Global blood transfusion devices market is expected to grow at a CAGR of around 6% during the forecast period. The global blood transfusion devices market is driven by upsurge in count of surgical procedures being carried out across the globe. Moreover, developments in terms of technology is expected to positively impact the growth of the market during the forecast period. Also, rise in number of blood related disorders is further expected to bolster the growth of market over the next few years.



The global blood transfusion devices market is segmented based on product, type, blood component, end user, company, and region. Based on product, the market can be categorized into apheresis systems, infusion devices, blood warmers, venous access devices, filters, and others. Out of these, the apheresis systems segment dominated the market in terms of largest market share until 2020 and is expected to maintain leading position in the market during the forecast period as well. This can be ascribed to its wide use for the treatment of leukostasis, which is caused by increased white blood count in leukaemia. In addition to this, apheresis system is also used for treating severe rheumatoid arthritis, in order to minimize the risk associated with antibody-mediated rejection of organ during, systemic lupus, goodpasture syndrome, polymyositis or dermatomycosis, and preeclampsia and eclampsia during pregnancy, which is anticipated to boost the growth of the segment over the coming years.



Major players operating in the global blood transfusion devices market include Fresenius Kabi AG, Grifols S.A., Terumo Corporation, B. Braun Melsungen AG, Becton, Dickinson, Company, Immucor Inc., Haemonetics Corporation, Kaneka Corporation, Macopharma SA, Tenko International Group Corp and others. The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnerships, agreements, and new developments.



Years considered for this report:

  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026

Objective of the Study:

  • To analyze and estimate the market size of global blood transfusion devices market from 2016 to 2020.
  • To estimate and forecast the market size of global blood transfusion devices market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global blood transfusion devices market based on product, blood component, end user, company and regional distribution.
  • To identify dominant region or segment in the global blood transfusion devices market.
  • To identify drivers and challenges for global blood transfusion devices market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global blood transfusion devices market.
  • To conduct pricing analysis for global blood transfusion devices market.
  • To identify and analyze the profile of leading players operating in global blood transfusion devices market.
  • To identify key sustainable strategies adopted by market players in global blood transfusion devices market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufacturers which could not be identified due to the limitations of secondary research. The publisher analyzed the manufacturers and presence of all major players across the globe.



The publisher calculated the market size of global blood transfusion devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.



Key Target Audience:

  • Blood transfusion devices manufacturers, suppliers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to blood transfusion devices
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.



Report Scope:


In this report, global blood transfusion devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:



Global Blood Transfusion Devices Market, By Product:

  • Apheresis Systems
  • Infusion Devices
  • Blood Warmers
  • Venous Access Devices
  • Filters
  • Others

Global Blood Transfusion Devices Market, By Blood Component:

  • Whole Blood
  • Plasma
  • RBC
  • Others

Global Blood Transfusion Devices Market, By End User:

  • Hospital
  • Ambulatory Surgical Centers
  • Dialysis Centers
  • Blood Bank
  • Other

Global Blood Transfusion Devices Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • South America
  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global blood transfusion devices market.



Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.




This product will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B Braun Melsungen AG
  • Fresenius Kabi AG
  • Grifols SA
  • Haemonetics Corporation
  • Immucor Inc
  • Kaneka Corporation

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Blood Transfusion Devices Market4. Executive Summary5. Voice of Customer
6. Global Blood Transfusion Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others)
6.2.2. By Blood Component (Whole Blood, Plasma, RBC, Others)
6.2.3. By End User (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Other)
6.2.4. By Company (2020)
6.2.5. By Region
6.3. Product Market Map
7. Asia-Pacific Blood Transfusion Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Blood Component
7.2.3. By End User
7.2.4. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Blood Transfusion Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Blood Component
7.3.1.2.3. By End User
7.3.2. India Blood Transfusion Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Blood Component
7.3.2.2.3. By End User
7.3.3. Australia Blood Transfusion Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Blood Component
7.3.3.2.3. By End User
7.3.4. Japan Blood Transfusion Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Blood Component
7.3.4.2.3. By End User
7.3.5. South Korea Blood Transfusion Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Blood Component
7.3.5.2.3. By End User
8. Europe Blood Transfusion Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Blood Component
8.2.3. By End User
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Blood Transfusion Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Blood Component
8.3.1.2.3. By End User
8.3.2. Germany Blood Transfusion Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Blood Component
8.3.2.2.3. By End User
8.3.3. United Kingdom Blood Transfusion Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Blood Component
8.3.3.2.3. By End User
8.3.4. Italy Blood Transfusion Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Blood Component
8.3.4.2.3. By End User
8.3.5. Spain Blood Transfusion Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Blood Component
8.3.5.2.3. By End User
9. North America Blood Transfusion Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Blood Component
9.2.3. By End User
9.2.4. By Country
9.3. North America: Country Analysis
9.3.1. United States Blood Transfusion Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Blood Component
9.3.1.2.3. By End User
9.3.2. Mexico Blood Transfusion Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Blood Component
9.3.2.2.3. By End User
9.3.3. Canada Blood Transfusion Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Blood Component
9.3.3.2.3. By End User
10. South America Blood Transfusion Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Blood Component
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Blood Transfusion Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Blood Component
10.3.1.2.3. By End User
10.3.2. Argentina Blood Transfusion Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Blood Component
10.3.2.2.3. By End User
10.3.3. Colombia Blood Transfusion Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Blood Component
10.3.3.2.3. By End User
11. Middle East and Africa Blood Transfusion Devices Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Blood Component
11.2.3. By End User
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Blood Transfusion Devices Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Blood Component
11.3.1.2.3. By End User
11.3.2. Saudi Arabia Blood Transfusion Devices Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Blood Component
11.3.2.2.3. By End User
11.3.3. UAE Blood Transfusion Devices Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Blood Component
11.3.3.2.3. By End User
11.3.4. Kuwait Blood Transfusion Devices Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product
11.3.4.2.2. By Blood Component
11.3.4.2.3. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
14.2.1. Fresenius Kabi AG
14.2.2. Grifols S.A.
14.2.3. Terumo Corporation
14.2.4. B. Braun Melsungen AG
14.2.5. Becton, Dickinson, and Company
14.2.6. Immucor Inc.
14.2.7. Haemonetics Corporation
14.2.8. Kaneka Corporation
14.2.9. Macopharma SA
14.2.10. Tenko International Group Corp
15. Strategic Recommendations16. About Us & Disclaimer
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Fresenius Kabi AG
  • Grifols SA
  • Terumo Corporation
  • B Braun Melsungen AG
  • Becton, Dickinson, and Company
  • Immucor Inc
  • Haemonetics Corporation
  • Kaneka Corporation
  • Macopharma SA
  • Tenko International Group Corp
Note: Product cover images may vary from those shown